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Abstract
Background: Burning mouth syndrome is a chronic disorder that is characterized by a burning sensation and a
normal clinical appearance of the oral mucosa. This condition often affects the health-related quality of life in
patients. As such, the aim of this study was to compare the health-related quality of life of patients with BMS and
healthy controls, using the validated Portuguese versions of the SF-36 and OHIP-49 questionnaires.
Methods: A calculated sample of Brazilian patients with BMS (n = 26) was compared with a control group (n = 27),
paired for gender and age. Sociodemographic information and clinical characteristics were obtained, and interviews
were conducted using the SF-36 and OHIP-49. To evaluate the normality of the variables, we used the Kolmogorov-
Smirnov test. The chi-square test, Fisher exact test and Mann-Whitney U-Test were used to compare
sociodemographic and clinical characteristics of individuals with BMS and controls Mann-Whitney U-test were carried
out to compare SF-36 and OHIP-49 between BMS patients and controls. The significance level was set at 0.05. To
compare the dimensions of the SF-36 and OHIP-49 between BMS patients and controls, we considered Bonferroni
correction. So for comparison of the dimensions, the significance level was set at 0.00625 for SF-36 and at 0.00714 for
OHIP-49.
Results: The clinical and demographic data were similar in both groups (P > 0.05). SF-36 scores were significantly
lower in all domains for patients with BMS (P < 0.00625). OHIP-49 scores were higher for individuals with BMS (P <
0.00714).
Conclusions: BMS has a negative impact on the health-related quality of life of individuals, as can be shown by
instruments such as the SF-36 and OHIP-49. So, the evaluation of quality of life might be useful for more
information about the nature and severity of BMS, to evaluate the effects of treatment protocols, in order to
improve their outcomes by means a humanized clinical practice.
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Introduction
Burning mouth syndrome (BMS) is a chronic disorder
that has evolved as a distinct clinical entity [1,2]. BMS is
more common in women in the middle to elderly age
range [2,3]. The prevalence is estimated to be 0.7-4.6%
of the general population [2]. BMS involves burning
sensations in the oral mucosa without evident clinical
pathology or laboratory findings [1-4]. The burning has
been reported to be of moderate or severe intensity and
may vary throughout the day [2,3]. Multiple factors have
been associated with these changes, and a variety of
symptoms could be simultaneously present, such as
xerostomia, dysgeusia, and psychological dysfunction.
Multiple sites in the oral cavity may be affected, with
the tongue being the most commonly affected site [2,4].
Because of the lack of consensus about the etiology of
BMS, establishing a treatment protocol for patients has
been extremely difficult [3].
It has been shown that BMS exerts a negative impact
on the quality of life of affected individuals [5-9].
According López-Jornet et al. [5], patients with BMS
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any medium, provided the original work is properly cited.have poorer scores on all scales that measure quality of
life. It is necessary to identify, explore, discriminate and
measure the oral quality of life for individuals with BMS
to devise specific strategies to improve the quality of life
of these patients [5]. Assessing the quality of life of
patients during the treatment of BMS may improve
patient-reported outcome measures, including quality of
life [6].
As such, the aim of this study was to compare the
health-related quality of life of patients with BMS and
healthy controls, using the validated Portuguese versions
of the SF-36 and OHIP-49 questionnaires.
Methods
Participants
The present investigation was a cross-sectional controlled
study that evaluated patients being seen in the Oral
Pathology clinic of Universidade Federal Minas Gerais
for the treatment of BMS symptoms. The Human
Research Ethics Committee of Universidade Federal de
Minas Gerais approved this study. All participants pro-
vided signed informed consent forms.
T h es a m p l es i z ec a l c u l a t i o nw a sp e r f o r m e dw i t ha =
0.05, power (1-b) = 0.95 and mean and standard deviation
values for the OHIP-49 from another study [5]. This for-
mula resulted in 21 patients for each group. However,
considering that Universidade Federal de Minas Gerais is
a reference center for the treatment of BMS, we evaluated
26 cases and 27 control patients. We evaluated a consecu-
tive sample of patients referred to the Oral Pathology
Clinic, School of Dentistry, Universidade Federal de Minas
Gerais and to the Oral Pathology Clinical of the Odilon
Behrens Hospital, a reference public Hospital in Belo
Horizonte, for the treatment of changes associated with
BMS, between August 2009 and December 2010.
The inclusion criteria for the diagnosis of BMS were in
accordance with those in the International Classification
of Headaches, which describes the following criteria for
the diagnosis, such as pain, itching, or burning in the
mouth present daily and persisting for most of the day,
with apparently normal oral mucosa and absence of local
and systemic diseases [7].
All patients underwent diagnostic blood tests (e.g.,
complete blood cell count, as well as levels of glucose,
iron, transferrin, vitamin B12, folic acid, antinuclear anti-
bodies (ANA), Anti-SSA/RO and Anti-SSB/LA) in order
to exclude exclude other disorders that cause burning in
the mouth as Sjogren’s syndrome, diabetes and anemia
[1,8,9]. Two independent examiners (two experts oral
pathologists) performed the clinical oral examinations to
confirm the absence of oral lesions.
The control group consisted of healthy patients seen
in the Dental Clinic of Universidade Federal de Minas
Gerais for periodic reviews of their dental condition.
They were not receiving any treatment at the time of
study, and the patients in the group had no history of
chronic pain syndrome or concomitant locoregional dis-
ease that caused oro-facial pain. Participants in the con-
trol group were selected for similar age and gender, on
the basis of the age and gender characteristics of the
subjects with BMS. All participants in the study were
from the Belo Horizonte metropolitan area in Minas
Gerais.
We recorded the following sociodemographic informa-
tion and clinical characteristics: age, gender, work, pre-
sence of systemic diseases, use of medications, denture
wear, tobacco and alcohol use and duration of symptoms.
The intensity of symptoms in patients with BMS was
measured using a Visual Analogue Scale (VAS). VAS con-
sists of a 10-cm line with two closed ends. One end indi-
cates ‘without burning’ while the other end indicates
‘unbearable burning sensation,’ representing the opposite
extreme. Patients were ask e dt os c o r eas i n g l ep o i n t
according to the best matched burning intensity [10].
Oral interviews with individuals with BMS and with
control subjectswere carried out between August 2009
and December 2010.
Questionnaires of quality of life
To assess quality of life, we appliedtwo questionnaires:
one that assesses general health (SF-36) and another
that evaluates the impact of oral health on quality of life
(OHIP-49).
The SF-36 is a questionnaire with 36 items across eight
components: physical functioning, physical role limita-
tions, physical pain, general medical health, vitality, social
functioning, emotional role limitations and mental health.
Higher scores indicate better health. This instrument
assesses the impact of general health on quality of life [11].
The Brazilian standard version of the SF-36 was validated
in our population [12].
The OHIP-49 consists of 49 questions organized into
seven dimensions: functional limitation, physical pain, psy-
chological discomfort, physical disability, psychological
disability, social disability, and handicap. The five response
categories are assigned values of 0-4 and indicate never
(0), hardly ever (1), sometimes (2), fairly often (3), and
very often (4) [13]. The Brazilian standard version of the
OHIP-49 was validated in our population.
Statistical analysis
We assembled a database using Statistical Package for
Social Sciences (SPSS) version 18.0. The descriptive statis-
tical analysis involved calculations of proportions,
measures of central tendency and variability for the socio-
demographic and clinical aspects as well as quality of life
variables. To evaluate the normality of the variables, we
used the Kolmogorov- Smirnov test. The chi-square test,
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compare sociodemographic and clinical characteristics of
individuals with BMS and controls Mann-Whitney U-test
were carried out to compare SF-36 and OHIP-49 between
BMS patients and controls. The significance level was set
at 0.05. To compare the dimensions of the SF-36 and
OHIP-49 between BMS patients and controls without
increasing in probability of type 1 error, we considered
Bonferroni correction. So for comparison of the dimen-
sions, the significance level was set at 0.00625 for SF-36
(0.05 divided by 8 dimensions) and at 0.00714 for OHIP-
49 (0.05 divided by 7 dimensions).
Results
The sample consisted of 26 individuals with BMS, 24
women (93.3%) and 2 men (7.7%), with a mean age of
63.62 ± 10.96 years and a median age of 64.0 years. The
control group consisted of 25 women (92.6%) and 2
men (7.4%), with a mean age of 64.59 ± 11.56 years and
a median age of 67.0 years. The age and gender distribu-
tions were similar in both groups (P > 0.05). The demo-
graphic characteristics for the 26 subjects with BMS and
the 27 control subjects are presented in Table 1.
The mean duration of BMS symptoms was 37.85 ±
43.13 (1-180) months. Among the subjects with BMS,
symptoms were measured using the VAS, yielding a
mean score of 8.81 ± 1.69.
SF-36 scores showed that the subjects with BMS,
when compared with the control group, had significantly
lower median scores across all of the domains (P <
0.00625) (Table 2).
Regarding the OHIP-49, we found higher scores for
individuals with BMS than for the control group.
Furthermore, significant differences were found for all
domains of the questionnaire (P < 0.00714) (Table 3).
Discussion
Health-related quality of life has been a widely used
instrument for assessing the physical and psychosocial
impact of chronic diseases, and this measure has led to a
better understanding of patients with these diseases and
their conditions for adaptation [11,14]. Patients with
BMS have been reported to have a diminished quality of
life [5,6,15-17]. Corroborating these findings, the present
study showed that BMS had a negative impact on the
health-related quality of life of individuals across all
domains by using instruments such as the SF-36 and
OHIP-49.
BMS is a disorder with symptoms that include persistent
burning sensations, xerostomia and taste disturbances
[1,3], in addition to several associated systemic changes,
such as psychological disorders, gastrointestinal maladies
and urogenital problems [18,19]. These disorders can con-
tribute to a diminished quality of life for these patients
[5,6]. In the present study, we did not evaluate specific sys-
temic alterations; however, no differences were observed
between the clinical data of patients with BMS and the
control subjects.
The SF-36 is a generic questionnaire with concepts that
are not specific to a certain age, disease or treatment
group; thus, the questionnaire allows for comparisons
between different diseases and different treatments
[11,12]. This questionnaire also includes perceptions by
individuals regarding their own health status across most
representative aspects of health [11]. The instrument,
when applied to individuals with BMS, proved that the
condition had a negative impact on the quality of life of
these patients compared with healthy controls and com-
pared with individuals with other diseases of the oral
mucosa [5,15]. In line with these findings, we observed
that individuals with BMS have a negative impact on all
domains of the SF-36.
The OHIP-49 was developed with the aim of providing a
comprehensive measure of dysfunction, discomfort and
disability reported by individuals that are attributed to oral
conditions [13]. In all studies on the quality of life of indi-
viduals with BMS, the OHIP-49 was used in its original
form or the short form, which also showed a negative
impact on the health- related quality of life of such indivi-
duals [5-9]. Corroborating these findings, the present
study found that all domains negatively affected the quality
of life of patients with BMS.
Burning mouth syndrome has been characterized by
changes associated with multiple symptoms and persistent
burning sensations [2-4,8]. Because its etiopathogenesis is
still unclear regarding the probable neuropathic origins,
no consensus has been established regarding effective
treatment [2,3]. Fewer than 3% of patients experience a
complete regression of symptoms over a period of five
Table 1 Comparisons of sociodemographic and clinical
characteristics of individuals with BMS and controls,
Brazil, 2009-2010
BMS Control P-value
Age (years) 64.0 (Median) 67.0 (Median) 0.75*
Women 24 (93.3%) 25 (92.5%) 1.0***
Work outside the home 9 (34.6%) 8 (29.6%) 0.69**
Systemic Diseases 25 (96.2%) 23 (85.2%) 0.35***
Medication use 24 (92.3%) 22 (81.5%) 0.42***
Antidepressive medication 10 (38.5%) 5 (18.5%) 0.11***
Antihypertensive medication 13 (50.0%) 18 (66.7%) 0.22***
Smoking 3 (11.5%) 2 (7.4%) 0.67***
Alcohol 2 (7.7%) 0 (0.0%) 0.23***
Dentures Wearers 16 (61.5%) 16 (59.3%) 0.86**
* Mann-Whitney U-Test ** Chi-square Test *** Fisher Exact Test.
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to their symptomatology, over three years of evolution and
high scores on the VAS. These factors may have contribu-
ted to the finding that patients with BMS in our study had
high scores within the OHIP-49 domains.
The scores in the Psychological Disability domain
reaffirms the mutual relationship between psychiatric
disorders and BMS, as described previously in other stu-
dies [2-4,19] and as also reported in the Mental Health
domain of the SF-36. This association should be further
investigated because it may have a negative impact on
the quality of life of patients with BMS and because it
intervenes directly in the biopsychosocial environment
of affected individuals.
T h em a j o r i t y( 8 4 . 6 % )o fp a t i e n t sh a ds e v e r eb u r n i n g
sensations [21] and have BMS for years, what could
explain the relationship between BMS and health-related
quality of life.
This study presents advantages and limitations asso-
ciated with a cross-sectional controlled study. Consider-
ing that we measured BMS and quality of life at the
same time, our associations could not be considered as
causal [22]. Besides, we have not evaluated dental caries.
This disease could have affected quality of life, despite
the two group of patients have had similar high propor-
tion of dentures wearers. Among the strengths of this
study was the presence of a calculated sample in a refer-
ence center for the treatment of disease.
Conclusions
BMS has a negative impact on the health-related quality
of life of individuals, as can be shown by instruments
such as the SF-36 and OHIP-49.
So, the evaluation of quality of life might be useful for
more information about the nature and severity of BMS,
to evaluate the effects of treatment protocols, in order to
improve their outcomes by means a humanized clinical
practice.
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